OM DENNE PODCAST 🔗

Værter:
Opdateringsfrekvens:
weekly
Gennemsnitlig lydlængde:
52 minutes
Gæsteinterviews
Engelsk
USA
79 episoder
siden 21. marts 2025
episodic

SENESTE EPISODE 🔗

This week, we chat with Simon Mølgaard, co-founder and chief executive officer of Teitur Trophics about results from its Parkinson’s disease trial, and have a conversation with Jordi Fàbrega, co-founder and CEO of CONNECTA Therapeutics, and Josep Prous, co-founder and chief scientific officer, abou…

SØG BLANDT TIDLIGERE EPISODER

Søg efter gamle afsnit af Base to Base Biotech.

SIDSTE EPISODER

This week, we chat with Lucas Decuypere, CEO and president of Allegro, about treatment of knee osteoarthritis with a nanotechnology injection, and Elin Trampe, the CEO of Dicot Pharma, a company developing a new form of erectile dysfunction treatment. Times: 01:46 Dicot Pharma 17:21 Allegro Allegro…
This week, we chat with Evan Appleton, chief scientific officer and co-founder of Intertwined, a company focused on understanding mammalian evolved protective traits, and how they can be transferred to humans. And we chat with Lew Bender, CEO of Intensity Therapeutics, which is pioneering an intrat…
This week, we have conversations with Marc Hedrick, CEO of Cerenome, about a combined approach to tackling central nervous system (CNS) cancers, and Shaun Holt, CEO of Alveo Technologies, about the potential for animal diseases to jump to humans, and what we can do about it. Times: 03:27 Cerenome 2…
Times: 03:17 Asgard Therapeutics 32:43 Waiv This week, we talk to a company in Lund, Asgard Therapeutics, and its co-founder and CEO Cristiana Pires, about in vivo direct cell reprogramming for cancer immunotherapy, and we chat about clinical diagnostics with Meriem Sefta, CEO of Waiv. Asgard Thera…
This week, our guests are Bryan McClellan, who conducted research on pancreatic cancer as a postdoctoral fellow at Dell Medical School, and William Matsui, the study's senior author and former executive vice dean for research at Dell Medical School; and Theialife president and CEO, Thomas Ruggia, a…
This week, our guests are chief scientific officer of Valo Health, Karin Conde-Knape, and Karsten Eastman, CEO of Sethera Therapeutics. Times: 03:06 Sethera Therapeutics 20:08 Valo Health Valo Health Our guest from Valo Health is chief scientific officer Karin Conde-Knape. As head of global drug di…
This week, we have a conversation about the Flexible Automation for Scalable Health (FLASH) programme, focused on the development of scalable cell-free DNA bioproduction capabilities. Our guests are John Schiel, program manager at ARPA-H; DNA Script co-founder and CTO, Xavier Godron; and John Nelso…
This week, we have a conversation Paweł Szczepański, CEO of JJP Biologics about specially-built antibodies to tackle autoimmune diseases and cancer. JJP Biologics JJP Biologics is a clinical-stage biotech that leverages its in-depth understanding of immune pathway science in autoimmune diseases and…
This week, we have a conversation with Peter G. Milner, founder and director of Renexxion, about GI motility disorders. Renexxion Renexxion, Inc. is a privately held US-headquartered clinical-stage biopharmaceutical company, with a subsidiary in Ireland, committed to developing new therapies for pa…
Ansvarsfraskrivelse: Podcasten og kunstværket, der er indlejret på denne side, er fra Jim Cornall, som tilhører dens ejer og ikke er tilknyttet eller godkendt af Listen Notes, Inc.